1-(Bromomethyl)-4-(trifluoromethyl)benzene → HCID 71204689, compound
Reaction equation
[F:1][C:2]1([F:24])[CH2:7][CH2:6][NH:5][C@@H:4]([C:8]([NH:10][C:11]2([C:14]3[CH:23]=[CH:22][C:17]([C:18]([O:20][CH3:21])=[O:19])=[CH:16][CH:15]=3)[CH2:13][CH2:12]2)=[O:9])[CH2:3]1.[F:25][C:26]([F:36])([F:35])[C:27]1[CH:34]=[CH:33][C:30]([CH2:31]Br)=[CH:29][CH:28]=1>>[F:24][C:2]1([F:1])[CH2:7][CH2:6][N:5]([CH2:31][C:30]2[CH:29]=[CH:28][C:27]([C:26]([F:25])([F:35])[F:36])=[CH:34][CH:33]=2)[C@@H:4]([C:8]([NH:10][C:11]2([C:14]3[CH:23]=[CH:22][C:17]([C:18]([O:20][CH3:21])=[O:19])=[CH:16][CH:15]=3)[CH2:12][CH2:13]2)=[O:9])[CH2:3]1Participants
3
Procedure
The title compound (D136) (30 mg) was prepared according to the general procedure described in Description 135 starting from (R)-methyl 4-(1-(4,4-difluoropiperidine-2-carboxamido)cyclopropyl)benzoate (D98) (47 mg) and 4-(trifluoromethyl)-benzylbromide (0.027 ml).
Sources & evidence
- ORD record
- ord-ebff8b264396494ca4a259cf56bb285b
- Source dataset
- uspto-grants-2015_11
- Patent number
- US09181279B2
Reaction notes
Loading…